these changes were related to an apparent functional loss and abnormal distribution of SK3 channels (K Ca 2.3 encoded by the KCNN3 gene), a class of small-conductance calciumactivated potassium channels. Electrochemical detection of dopamine showed that this observation was associated with an enhanced dopamine release in presymptomatic transgenic mice and a drastic reduction in symptomatic animals. These changes occurred in the context of a progressive expansion in the CAG repeat number and nuclear localisation of mutant protein within the substantia nigra pars compacta. Conclusions: Dopaminergic neuronal dysfunction is a key early event in HD disease progression. The initial increase in dopamine release appears to be related to a loss of SK3 channel function, a protein containing a polyglutamine tract. Implications for polyglutamine-mediated sequestration of SK3 channels, dopamine-associated DNA damage and CAG expansion are discussed in the context of HD. Key Words Dopamine · Amperometry · KCNN3 · Huntingtin · CAG expansion · Substantia nigra · Neurodegeneration · R6/1 · Polyglutamine Abstract Background: Huntington's disease (HD) is a late-onset fatal neurodegenerative disorder caused by a CAG trinucleotide repeat expansion in the gene coding for the protein huntingtin and is characterised by progressive motor, psychiatric and cognitive decline. We previously demonstrated that normal synaptic function in HD could be restored by application of dopamine receptor agonists, suggesting that changes in the release or bioavailability of dopamine may be a contributing factor to the disease process. Objective: In the present study, we examined the properties of midbrain dopaminergic neurones and dopamine release in presymptomatic and symptomatic transgenic HD mice. Methods and Results: Using intracellular sharp recordings and immunohistochemistry, we found that neuronal excitability was increased due to a loss of slow afterhyperpolarisation and that
Introduction
Huntington's disease (HD) is a fatal neurodegenerative disorder that belongs to the polyglutamine family of trinucleotide repeat diseases. For HD, a repeat CAG codon occurs within the first exon of the gene encoding the protein huntingtin [1] , and the age of onset of this disorder is inversely correlated to the length of the CAG repeat expansion [2] . In humans, the symptoms which usually appear in the third to fifth decades of life often include cognitive disturbances that can over time develop into dementia [3] . The primary sites of neurodegeneration are the striatum and cerebral cortex [4] [5] [6] [7] , and neurological investigations suggest that early cognitive deficits may already be apparent in patients before the onset of classical symptoms [8] [9] [10] [11] [12] . Furthermore, post-mortem studies [7] reveal that both motor and cognitive symptoms can appear in the absence of overt neuronal cell loss, suggesting that impaired cognition is likely to be caused by synaptic and neural dysfunction rather than a consequence of cell death. With the introduction of genetic testing for the HD gene it is now possible to assess the cognitive performance of known gene carriers prior to the onset of overt motor symptoms. Importantly, such studies report that deficits in working memory, executive function [13, 14] and certain aspects of recognition memory [15] are early events and occur prior to the onset of overt symptoms. These differences may reflect the variety of transgenic models studied.
The neurotransmitter dopamine is a powerful modulator of the synaptic plasticity believed to underlie these forms of cognition, and dopaminergic (DA) deficits have been reported in presymptomatic and early-state symptomatic human HD gene carriers. PET scanning studies have revealed that the density of functional D 1 -and D 2 -dopamine receptors are reduced in the striatum and cortex of these individuals [16] [17] [18] [19] , indicating that changes in the DA system are amongst the earliest detected in HD. However, the role of dopamine as a potential pathogenic agent in HD remains controversial [20, 21] , and human post-mortem studies have yielded inconsistent results in terms of changes in brain dopamine levels.
The identification of the HD gene in 1993 [22] has led to the successful creation of several genetically modified mouse and rat models that recapitulate aspects of the human disease (reviewed by Bates and Murphy [23] ). Studies using these genetic models have also added to the controversy, with some laboratories reporting dramatic reductions in striatal dopamine levels [24] [25] [26] [27] or loss of dopamine signalling [28, 29] and others suggesting that dopamine levels may be elevated [30] or toxic [31, 32] . Surprisingly, very little is known about the properties of the HD midbrain DA neurones, the main source of dopamine in the brain. We report here a series of experiments designed to assess the properties of these neurones in terms of their (1) functional membrane characteristics; (2) ability to release dopamine; (3) expression of key proteins, and (4) CAG repeat expansion profile. We have used age-matched transgenic mice carrying 89 (R6/1-89Q line) and 116 CAG repeats (R6/1 line) corresponding to a prodromal and symptomatic state, respectively; an approach that has enabled us to characterise the nature of DA dysfunction in models of pre-manifest and manifest disease.
Material and Methods

Intracellular Recording of DA Neurones
Experiments were conducted in acute slices prepared from adult mice aged 7-10 months. At this age, R6/1-89Q mice are prodromal while R6/1 mice are close to the end-stage of the disease [33] . Coronal brain slices containing midbrain were prepared from transgenic and non-transgenic littermates, obtained from an in-house R6/1 mouse colony, maintained by breeding hemizygotic R6/1 and R6/1-89Q males with B6/CBA females housed in an enriched environment [34] . Briefly, mice were sacrificed by cervical dislocation and decapitation in accordance with UK legislation (Animal Scientific Procedures Act, 1986). Measures were taken to minimise pain and discomfort. The brain was rapidly removed and placed in chilled (1-4 ° C) artificial cerebrospinal fluid (aCSF; composition in m M : 120 NaCl, 4.7 KCl, 2.5 CaCl 2 , 1.2 MgSO 4 , 1.2 NaH2PO 4 , 26 NaHCO 3 and 11.5 D -glucose). The cerebellum was removed and the brain glued at the caudal aspect to a silicone stage. Two 400-μm-thick coronal sections containing the substantia nigra pars compacta (SNc) and ventral tegmental area ( ∼ 3 mm posterior to the bregma) were obtained from each mouse using a manual vibratome (Campden Instruments Ltd., Sileby, UK). Slices were then transferred into an interface recording chamber (Scientific Systems Design Inc., Mercerville, N.J., USA) heated at 34 ° C (Proportional Temperature Controller; Scientific Systems Design Inc.) and continuously perfused with oxygenated aCSF (95% O 2 and 5% CO 2 , Carbogen, British Oxygen Company) at a flow rate of ∼ 200 μl/min. Once placed in the recording chamber, slices were allowed to recover for >90 min prior to recording. Intracellular recordings were obtained from neurones in the SNc/ventral tegmental area with sharp electrodes (impedance 70-150 MΩ) filled with 3 M potassium acetate and connected to an Axoclamp 2B DC amplifier (Axon Instruments Inc., Foster City, Calif., USA) operated in bridge mode (current clamp). Electrical signals were visualised on an oscilloscope and digitised via an ITC-16 computer interface A/D converter (Instrutech Corp., Port Washington, N.Y., USA) coupled to a personal computer (MAC-G3, Apple Macintosh Inc., USA). Responses were collected and analysed using A/Dvance P3.61g software (Robert McKellar Douglas, Vancouver, B.C., Canada).
Passive membrane properties were recorded by stepwise current injections (-1 to +1 nA, 500 ms) to generate a current-voltage (I/V) relationship, including positive pulses to assess action potential (AP) characteristics. Passive membrane properties were inferred from the I/V curve except membrane time constants (T 0 ), which were determined by analysing the time course of the membrane voltage deflection according to the method described by Rall [35, 36] . This method consists in 'peeling exponentials' by plotting the natural log of the response expressed as a percentage of the peak negative potential ( fig. 1 f) . In our recordings, the late portion of the charging phase (for time points between 5 and 15 ms) always fitted a linear regression (0.85< R 2 <0.99), of which the slope was equal to -1/T 0 . For each cell and hyperpolarising intensity, the membrane time constant was thus calculated using this equation. Rall's method also allows determination of the equalizing time constant (T 1 ), which represents the time required for the current to spread to the proximal dendrites. T 1 is given by the second-order exponential observed for time points earlier than 5 ms in figure 1 f. This value could thus be obtained by plotting the difference between the membrane time constant regression line from the points lying above this line, normalising the y-intercept of this new line (0.77< R 2 <0.99) to 100% and reading T 1 as the negative inverse of the slope. From two time constants, the somatodendritic electronic length could be estimated using the relation: L = π (T 0 /T 1 ) -1/2 . Dopamine neurones were recognised by their characteristic electrical properties ( fig. 1 ) ; that is, a long-duration AP with a typical hump on the downward slope ( fig. 1 d) , a prominent time-dependent rectification and a delayed repolarisation following cessation of a hyperpolarising current pulse ( fig. 1 c) [36] [37] [38] . Duration and amplitude of the fast afterhyperpolarisation (AHP) were measured between the lowest point at the end of the hyperpolarisation phase and the switching point from upslope to downslope. Duration and amplitude of the slow AHP (sAHP) were measured between the latter switching point (end of the fast AHP; fAHP) and the transition point between the AHP and the slow oscillatory potential. The latter point was determined at the intersection between the regression lines of the linear part (upon 50 ms) of the AHP and the slow oscillatory potential.
Electrochemical Detection of Dopamine Release
Slices were prepared from adult mice as described above, with the exception that a single 400-μm coronal section of the caudate putamen was prepared ( ∼ 0.5 mm anterior to the bregma) from each animal. The slice was then transferred into an interface chamber and perfused with heated (28 ° C), oxygenated aCSF at a flow rate of ∼ 200 μl/min. Slices were left to equilibrate for >90 min prior to recording. Dopamine release was recorded using constant potential amperometry as this technique provides good temporal resolution and has been shown to be efficient for dopamine detection in striatal slices [39] . For this, +300 mV versus Ag/AgCl was applied to a carbon fibre electrode using the MicroC potentiostat (World Precision Instruments, Hertfordshire, UK). When present at the tip of the electrode, dopamine becomes oxidised, thereby generating a measurable faradaic current [39] that exhibits a linear relationship to dopamine concentrations ranging from 0.1 to 10 μ M ( fig. 2 a) . Recording carbon fibre electrodes (impedance 0.35-1.9 MΩ; CF30-100; World Precision Instruments) were connected to a MicroC potentiostat (World Precision Instruments) and the recorded signal sent to an ITC-16 computer interface A/D converter coupled to a Macintosh G3 personal computer. Responses were collected using A/Dvance P3.61g software which was also set to control Neurolog isolated stimulator boxes (NL800, Digitimer Ltd., UK). Calibration of the electrode was carried out for each experiment.
Stimulation of the striatal tissue was performed using stainless steel bipolar electrodes (World Precision Instruments) placed in the dorsolateral striatum. The recording electrode was positioned approximately 500 μm ventral to the stimulating electrode, equidistant from the two poles of the stimulating electrode. Input/ output (I/O) relationships were obtained by incrementally stimulating the tissue once every 5 min (0.0033 Hz, 40 μs, 20-500 μA). The stimulation strength giving the maximal amplitude was chosen as test shock for subsequent experiments. The maximum level of dopamine release (DAmax) was obtained by averaging seven stimulations (35 min in total) at which dopamine release was maximal. Paired-pulse experiments consisted in applying two identical stimuli every 5 min with increasing inter-pulse intervals, from 50 ms to 50 s. Since the duration of the responses could last up to 1,000 ms, for intervals shorter than this, the average response to a single stimulus (i.e. the first response obtained for intervals longer than 1 s) was subtracted from the signal. Data were analysed for each interval by plotting the amplitude of the second response (P2) as a percentage of the first (P1) using the following formula: (P2/P1 × 100) -100. The DA nature of the response was verified by inhibiting dopamine release through stimulation of D2-like autoreceptors at DA terminals with 1 μ M quinpirole [40] . Such treatment unequivocally suppressed our evoked faradaic responses (online suppl. fig. 1 ; for all online suppl. material, see www.karger.com/doi/10.1159/000375126).
SK3/Tyrosine Hydroxylase/S830 Immunofluorescence
Triple immunodetection of tyrosine hydroxylase (TH), mutant huntingtin and SK3 channels in the SNc was performed on 6-month-old R6/1 animals (R6/1: n = 5, non-transgenic littermates: n = 5), as well as presymptomatic 10-and symptomatic 20-month-old R6/1-89Q mice (R6/1-89Q: n = 5, non-transgenic littermates: n = 5, for each age). Mice were perfused with 4% paraformaldehyde, pH 7.4. Brains were subsequently processed in 30-μm serial coronal sections by means of a vibrating microtome (VT1000S, Leica, Milton Keynes, UK). For each brain, 8 evenly spaced (180 μm) sections covering the total length of the SNc were taken starting from the principal mammillary tract and were processed for immunohistochemistry. After three successive rinses in 0.1 M PBS, slices were transferred to a 0.5% BSA/0.2% Triton X-100/0.1 M PBS (1× PBT) solution for 30 min and then incubated with constant agitation for 24 h at 4 ° C in the primary antibodies cocktail [sheep anti-S830 polyclonal antibody, 1: 5,000 (kind gift from Prof. Gillian Bates, FRS); mouse anti-TH polyclonal antibody, 1: 10,000 (Abcam, UK), and rabbit polyclonal anti-SK3 (Cterminal) antibody, 1: 1,000 (ab83737, Abcam)] diluted in 1× PBT and rinsed three times in 0.1 M PBS. Sections were then incubated with the secondary antibodies cocktail (Alexa-555 conjugated donkey anti-sheep, Alexa-488 goat anti-mouse and Alexa-633 goat anti-rabbit, 1: 1,000; Invitrogen) for 2 h at room temperature. After a last set of three rinses, sections were mounted using Vectashield containing DAPI for confocal microscopy analysis (Zeiss LSM700 confocal microscope). Controls consisted in omitting the primary antibody for each target (except for TH) and were performed independently.
All sections used for analysis were processed on the same day and with the same buffers and antibodies cocktails. All images The membrane time constant (T 0 ) was calculated by plotting the natural log of the response expressed as percentage of the peak negative potential (% Δ Emax) to 'peel' the first order exponential for time points lying between 5 and 15 ms. T 0 could then be read as the slope-negative inverse of the regression line. The second-order exponential for time points earlier than 5 ms was peeled by plotting the difference between the T 0 regression line from the points lying above this line and normalising the y-intercept of the T 1 regression line to 100%. T 1 could then be read as the slope-negative inverse of the normalised T 1 regression line.
were acquired using a 40× magnification lens and a numerical zoom set to 1×. Randomly chosen acquisition fields were taken from the SNc which was detected based on the TH signal. Image acquisition was done using a constant configuration for the SK3 signal detection (488 channel) across the whole set of sections. Quantification of fluorescence intensity was performed after acquisition of 3 acquisition fields (within the SNc) per slice (n = 6 slices per animal). Masks for cell shapes, nuclear regions and HTT aggregates were designed independently for each image on specific channels (SK3/TH, DAPI and S830, respectively) using Adobe Photoshop. Fluorescence intensity of SK3 signals was quantified using these masks on the adequate channel image (green/488). This was performed using a custom Matlab (Mathworks) script enabling categorisation of regions of interests (ROI; nucleus vs. cytoplasm, aggregate-positive vs. -negative cells, TH vs. non-TH cells) as well as quantification of the mean fluorescence intensity for each ROI.
TH Immunostaining
Animals were sacrificed by cervical dislocation and immediate decapitation in accordance with UK legislation (Animal Scientific Procedures Act, 1986), brains removed and immersion fixed in 10% neutral buffered formol saline solution (VWR International, UK) for 2 weeks on a low-speed shaker at room temperature. Following fixation, the brains were bisected along the midsagittal plane and the right cerebral hemispheres processed into paraffin wax using a tissue processing unit (Shandon Hypercenter XP, UK). Paraffin-embedded tissues were then serially sectioned at 10 μm in the sagittal plane using a base sledge microtome (Leica SM2400). Individual brain/wax sections were first flattened by placing them onto a water bath heated at 35 ° C. Sections were then transferred onto APES-coated slides and incubated at 40 ° C for 2 days. For immunostaining, wax was removed from the section using xylene. Samples were subsequently rinsed in IMS (industrial methylated spirit) and transferred to a solution of methanol-H 2 O 2 for 90 min to block endogenous peroxidase. Sections were briefly rinsed in water, transferred into PBS solution and incubated in normal swine serum (Dako, UK) blocking reagent for 90 min. After this blocking step, sections were incubated with TH (dilution 1: 100) primary antibody for 16 h at room temperature. After PBS rinses, sections were incubated in biotinylated rabbit anti-sheep secondary antibody (swine anti-rabbit) for 90 min, PBS washed and incubated in ABC solution (avidin-biotin complex, Vector Laboratories, UK) for 90 min. Samples were washed again with PBS and placed in diaminobenzidine solution (0.5 mg/ ml in PBS and 0.05% of H 2 O 2 ) for 6 min and lightly counterstained 98 with Harris's haematoxylin to detect nuclei. Sections were finally dehydrated using a growing gradient of IMS (70, 95 and 100%) and 100% xylene. Slides were mounted with Permount (CellPath, UK). Digital images were captured using a high-resolution digital camera (JVC) mounted on a Nikon Microphot-FX microscope. For each animal, 10 digital images were captured from a series of sections taken through the whole rostro-caudal axis of the SNc or dorsal striatum.
Statistical Analyses
Data for each condition were pooled and expressed as mean ± SEM. One-or two-way ANOVAs were carried out as appropriate using Statistica 6.1 (StatSoft Inc.) or GraphPad Prism 5.00. Normal distribution of the datasets was verified using the KolmogorovSmirnov test, and the Newman-Keuls test was used for post hoc analyses. When datasets were found to display a distribution significantly different from normal, the non-parametric KruskalWallis H test was used. Differences between means for experimental and control conditions were considered statistically significant when p < 0.05.
Somatic CAG Repeat Length Analysis
CAG length analysis was performed on both mRNA and genomic DNA (gDNA). For mRNA analysis, SNc was dissected from freshly sacrificed R6/1-89Q mice and mRNA isolated using RNAspin reagents (GE Healthcare, UK) and a cDNA copy generated using cloned AMV reverse transcriptase (Invitrogen). cDNA synthesis was performed using a reaction mixture containing 5 μ M of HD4 primer (5 ′ GGCGGCTGAGGAAGCTGAGGA 3 ′ ), 10 m M dNTPs, cDNA synthesis buffer, 0.05 M DTT, 20 units of RNase-OUT and 7.5 units of cloned AMV reverse transcriptase. For each of the tissue samples, a negative control reaction was also prepared. Reactions were incubated for 50 ° C (60 min), 85 ° C (5 min) and stored at -20 ° C.
CAG repeat length analysis was first performed on samples of cDNA that had been serially diluted in TE buffer containing 0.1 μ M HD4 primer. Dilutions generating optimum amplification of discrete alleles were then used as templates for multiple independent PCR reactions, each containing 0.2 m M dNTPs, 0.5 μ M of IR-800-labelled HD1 (5 ′ ATGAAGGCCTTCGAGTCCCT CAA GTCCTTC 3 ′ ) and HD4 (5 ′ GGCGGCTGAGGAAGCT GAGGA 3 ′ ) primers, 1× PCR buffer (Sigma, UK), 0.25% of DMSO and 1 unit Taq DNA polymerase (Sigma). Reactions were heated to 94 ° C for 2 min followed by 38 cycles of 94 ° C for 30 s, 68 ° C for 30 s and 72 ° C for 2 min and followed by a final extension of 10 min at 72 ° C in an Opticon 2 DNA Engine (MJ Research Inc., USA). Discrete alleles were resolved and visualised using 5% denaturing polyacrylamide electrophoresis on a Li-COR 4200 DNA sequencer. Individual alleles were sized against known size markers, their frequency scored and compared in a graph form to provide a visual representation of CAG expansion profile.
For gDNA analysis, DNA was first isolated from fresh SNc tissue samples after homogenisation, lysis and phenol-chloroform extraction [33] and stored at -20 ° C until analysis. After quantitation at 260 nm (Gene Quant Pro, Amersham Biosciences, UK), template DNA stocks were created by serial dilution in TE buffer containing 0.1 μ M HD1 primer to a final concentration between 0.1 and 0.5 ng/μl. CAG alleles were amplified in reactions containing 0.2 m M dNTPs, 0.5 μ M of each HD1 and IR-800-labelled HD4 primers, 1× PCR buffer (Sigma), 0.25% DMSO and 1 unit of Taq DNA polymerase (Sigma). Multiple independent PCR reactions were performed and resolution and detection were as described for cDNA analysis.
Results
Electrophysiological Profile of DA Neurones in Transgenic Mice
Passive membrane properties of transgenic DA cells (R6/1: n = 16, R6/1-89Q: n = 17) were similar to those of non-transgenic DA neurones (n = 48; table 1 ; fig. 3 a) . No significant genotype effect could be detected with respect to resting membrane potential, input resistance, membrane time constant, electronic length and capacitance, thereby suggesting that the integrity of the membrane of transgenic DA neurones was not affected by the presence of either 89 or 116Q transgenic protein. Yet, spontaneous APs of R6/1 and R6/1-89Q DA neurones revealed a marked reduction of the sAHP ( table 2 ; fig. 3 b, c; p < 0.001). This impairment was more prominent in symptomatic R6/1 as compared to R6/1-89Q neurones (p < 0.001) and resulted in an increased firing rate ( fig. 3 b; controls: 1.9 ± 0.2 Hz; R6/1-89Q: 3.9 ± 0.2 Hz; R6/1: 3.5 ± 0.2 Hz; p < 0.05).
The main function of the AHP is to regulate post-spike excitability. This, together with the slow oscillatory potential, regulates the spontaneous firing rate of DA neurones as well as neuronal excitability in response to depolarising inputs [36, 41] . The latter phenomenon is termed accommodation and was assessed by injecting depolarising square current pulses of increasing intensities through the recording electrode. Non-transgenic DA neurones One-way ANOVA revealed that among the different AP characteristics, the AHP and AP size were selectively impaired in the transgenic DA neurones. R6/1-89Q: † p < 0.05, † † p < 0.01, † † † p < 0.001. R6/1: * p < 0.05, ** p < 0.01, *** p < 0.001. typically responded by a rapid accommodation of their firing rate, i.e. increasing the inter-spike interval as the depolarisation persists ( fig. 4 a) . In contrast, DA neurones' firing upon depolarisation was severely impaired as shown by an increased instantaneous frequency ( fig. 4 b; controls: 76.1 ± 7.1 Hz; R6/1-89Q: 103.7 ± 9.4 Hz; R6/1: 116.4 ± 10.3 Hz; p < 0.001) and total frequency ( fig. 4 c; controls: 8.04 ± 0.53 Hz; R6/1-89Q: 15.33 ± 1.81 Hz; R6/1: 10.14 ± 1.51 Hz; p < 0.001). The ability of DA neurones to accommodate their firing rate upon excitation was more accurately assessed by calculating the percentage change between consecutive inter-spike intervals. Figure  4 d shows that in non-transgenic DA neurones the maximal level of accommodation occurred at the beginning of the depolarising pulse. This initial accommodation was consistently impaired in transgenic cells ( fig. 4 d; p < 0.001). Together, these data indicate that in HD DA neurones, sAHP dysfunction results in a markedly impaired accommodation and, as a consequence, drives the transgenic neurones into a hyper-excitable state.
Real-Time Measure of Striatal Dopamine Release
We next reasoned that this hyper-excitability of DA neurones may translate in an increased release of dopamine at the synaptic terminals [42] . In order to test this hypothesis, we used constant potential amperometry in striatal slices to examine the evoked release of dopamine since the striatum is exquisitely vulnerable in HD and receives the highest density of DA input in the brain. Single electrical stimulations were sufficient to generate faradaic signals consisting of a brief stimulus artefact, a relatively rapid rise reaching its maximum at about 400-500 ms and a slow decay terminating at baseline approximately 2,500-3,000 ms following stimulation ( fig. 2 b) . In order to confirm the faradaic nature of the signal, the electrode was regularly set to zero instead of +300 mV. Under such conditions, no response to electrical stimulation could be recorded, indicating that signals obtained at +300 mV were indeed due to redox reactions at the tip of the electrode.
Input/output relationships revealed that dopamine release was increased in R6/1-89Q mice ( fig. 2 c ; DAmax values for non-transgenic slices: 2.9 ± 0.3 μ M , n = 6; R6/1-89Q: 4.2 ± 0.4 μ M , n = 8; p < 0.05), while in slices prepared from R6/1 mice, the release of striatal dopamine was drastically reduced (DAmax 0.8 ± 0.2 μ M , n = 5; p < 0.001). We also assessed short-term plasticity of dopamine release by applying paired-pulse stimulation at different inter-stimulus intervals and found no difference in prodromal R6/1-89Q mice as compared to control littermates, whereas R6/1 regulation of dopamine release was again severely compromised ( fig. 2 d) . In all, these data suggest that enhanced dopamine release may underlie the early cognitive impairment reported in presymptomatic HD gene carriers, whilst the apparent loss of dopamine is entirely consistent with the hypokinetic state associated with end-stage HD [43] .
SK3 Immunostaining
The regulation of tonic firing in DA neurones is mediated by SK3 channels, a class of calcium-sensitive smallconductance potassium channels that generates the sAHP [44, 45] . The SK3 channel carries a polyglutamine stretch close to its intracellular NH 2 terminus and thus potentially constitutes a target for the expanded polyglutaminecontaining transgenic protein, which may prevent the insertion of SK3 channel subunits into the membrane during synthesis or disrupt channel function. In order to ascertain whether the expression of SK3 channels in DA neurones is influenced by polyglutamine-containing transgenic protein, we assessed the expression of both the SK3 channel protein and the transgenic protein in DA neurones (TH-positive) in the SNc. We first performed an immunocytochemical analysis using a triple α-SK3, α-TH, and α-S830 staining in the SNc of symptomatic R6/1 mice (n = 5) compared to their aged-matched non-transgenic littermates (n = 5). Interestingly, quantification of the SK3 levels in TH-positive cells (DA neurones) revealed a marked increase in R6/1 cells as compared to controls ( fig. 5 a, b; +41.40 ± 5.60%; p < 0.05). Furthermore, this ef- Interestingly, SK3 staining was found to be higher in TH-negative cells (p < 0.0001). However, quantification revealed no change in the amount of SK3 immunoreactivity in R6/1 non-DA cells when compared with nontransgenic ones ( fig. 5 c; -0.82 ± 2.41%; p > 0.05). Taken together, these data suggest that the alterations in SK3 protein localisation in R6/1 SNc are specific to DA neurones.
We then examined expression of the SK3 protein in R6/1-89Q animals before and after phenotype development by performing a similar immunocytochemical analysis, focusing on TH-positive cells in material prepared from 10-month-old animals (prodromal R6/1-89Q: n = 5; non-transgenic littermates: n = 5) and 20-month-old animals (symptomatic R6/1-89Q: n = 5; non-transgenic littermates: n = 5). SK3 levels were found to be significantly increased in R6/1-89Q TH-positive cells at both ages, indicating that this change in expression is an early event in disease progression ( fig. 6 ; +38.30 ± 4.06%, p < 0.001 at 10 months and +14.20 ± 3.741, p < 0.05 at 20 months).
CAG Repeat Expansion in the SNc
The observation that the age of HD onset is inversely correlated with the repeat length implies that the deleterious consequences of the polyglutamine stretch are length dependent. Cells in the most severely affected brain regions in HD have been shown to undergo extensive repeat expansion long before disease onset [46] [47] [48] suggesting that somatic repeat expansion may be a cause or a consequence of cellular dysfunction. In order to assess whether CAG repeat expansion is a characteristic of DA neurones in HD and an early event in neuronal dysfunction, we assessed the extent of CAG repeat expansion in excised samples of SNc from R6/1-89Q mice at 2, 12 and 15 months of age (MO).
gDNA analysis revealed that somatic CAG repeat instability occurred as early as at 2MO in the SNc ( fig. 7 a) . Repeat instability comprised alleles with both expansions and truncations. At 12MO, the instability observed was more pronounced and displayed a bias towards ex- 20MO ( b ) . c SK3 mean fluorescence analysis revealed that the protein expression increases at both pre-manifest and manifest disease stages. * p < 0.05; *** p < 0.001 . pansion. At 2MO, the largest expansions observed in 1.89% of the alleles was 11 repeats, whereas 46.80% at 12MO displayed an expansion >10 repeats with a maximum of 47 repeats. Overall, 66.04 and 82.98% of cells located in the SNc displayed an increase in CAG repeat length at 2 and 12MO, respectively (2MO mean expansion: 3.14 ± 0.4 repeats, 12MO mean expansion: 16.56 ± 2.21 repeats).
Since elongation of the CAG repeat in the gDNA may not be transcribed into mRNA, repeat instability analysis was also performed on cDNA products obtained from mRNA samples from the SNc. Akin to the gDNA data, the mRNA expansion profile revealed progressive elongations at every age studied ( fig. 7 b; 35.71% of cells at 2MO with a mean expansion of 5.80 ± 3.33 repeats and 77.34% of cells at 15MO with a mean expansion of 17.28 ± 1.18 repeats).
Altogether, our gDNA and cDNA CAG repeat analyses suggest that cells within the SNc expressing the transgene contain a protein with a progressively lengthening stretch of polyglutamine. This has the potential to interact with and disrupt the function of other polyglutaminecontaining proteins present in these cells, such as SK3, and this would increase as localised CAG expansion occurs with ageing.
Discussion
This study is the first to directly address the intrinsic functional membrane properties of midbrain DA neurones in mouse models of HD. We have used tissues that correspond to both pre-manifest and manifest disease. In order to control interference with ageing processes and to focus on the degree of severity of the disease only, we used mice carrying either a 116 or 89 polyglutamine repeat in an age range at which polyglutamine repeat of the transgenic protein determines the pathogenic phenotype, such that mice carrying 116 repeats are nearing the end stage of the disease phenotype [49] , whereas those carrying 89 repeats have yet to develop an overt phenotype [33] . We report a marked increase in the excitability of DA neurones that is evident at an early stage of disease progression. This results in profound alterations in dopamine release which presents as an increased evoked release in the presymptomatic condition and, in sharp contrast, near extinction in overt disease. In addition, these changes occur in the context of ongoing CAG repeat expansion and disruption of SK3 channels expression in the DA neurones of the SNc.
Membrane Properties
The passive membrane properties of control DA neurones were found to be comparable to those reported elsewhere [37, 38, [50] [51] [52] . Importantly, R6/1-89Q and R6/1 DA neurones exhibited normal membrane properties ( table 1 ) suggesting that they are relatively preserved from morphological and intrinsic degenerative changes. This is in marked contrast with several HD mouse studies that report changes in the passive membrane properties of striatal medium spiny neurones [53] [54] [55] , hippocampal pyramidal cells and cortical neurones [28, 56] . However, the tonic properties of transgenic DA cells were found to be profoundly altered. The most conspicuous alteration displayed by both R6/1 and R6/1-89Q DA neurones was a striking impairment of the sAHP. In DA neurones, the AHP is mediated by a class of smallconductance calcium-activated potassium channels known as SK3 channels [45, 47] . The profound loss of the AHP, and the consequent increase in neuronal excitability and reduced accommodation associated with it, strongly suggest that there is a functional lesion at the level of the SK3 channel. The alterations in the level of SK3 expression we observed in both the R6/1 and R6/1-89Q line support the view that such lesion is an early event in the pathologic phenotype of DA neurones in HD.
Dopamine Release
One would predict that an increase in neuronal excitability of DA cells might manifest as a functional increase in the release of dopamine from these cells, and indeed this seems to be the case for presymptomatic R6/1-89Q mice. Furthermore, it has recently been shown using microdialysis that dopamine and its metabolites are markedly increased in a conditional mouse model deficient in SK3 channels [57] . In contrast, studies in the short-lived R6/2 mouse line suggested that dopamine release is actually reduced [24, 27] , though one study indicated a transient increase in the activity of TH in presymptomatic R6/2 mice [58] . Importantly, two recent studies provide indirect functional evidence that DA tone is enhanced in the striatum during early-stage disease [59, 60] . In one study using R6/1 mice, the majority of striatal neurones exhibited high γ-oscillations, a form of high-frequency activation not normally seen in normal mice. Such oscillations are reported in Parkinson's disease patients undergoing dopamine supplementation and in rats treated with dopamine agonists [59, 60] . Our finding that striatal dopamine release is greatly augmented in presymptomatic R6/1-89Q mice supports the view that enhanced levels of striatal dopamine is a feature of early-stage disease and may underlie emergent properties such as high γ-oscillations. Furthermore, the decrease in dopamine receptor densities reported in the striata of presymptomatic and early symptomatic human gene carriers [16] [17] [18] [19] may also reflect a compensatory downregulation in dopamine receptor expression levels in these individuals in response to elevated levels of striatal dopamine.
The prediction that increased neuronal excitability leads to enhanced dopamine release does not hold for symptomatic animals. In sharp contrast, dopamine release was found to be severely reduced in striatal slices from R6/1 mice and is in accordance with previous investigations showing that dopamine release is also reduced [26, 61] . The aetiology of this failure in dopamine release is likely to be more complex. Indeed, whilst in the early stage of the disease dopamine production and striatal DA afferents appear intact as suggested by our TH immunostaining of 7-month-old R6/1-89Q mice (online suppl. fig. 2 ), in more advanced HD, striatal neurodegeneration occurs and is associated with a reduction in nigrostriatal fibres [62] [63] [64] likely to underlie the reduced DA release we and others report [24, 26] . Yet, Petersén et al. [61] demonstrated a reduction in extracellular dopamine in 4-month-old R6/1 mice but found no change in striatal TH immunoreactivity (occurring later in R6/1 mice [63] ), indicating that defects in release mechanisms per se are also at play. In line with this, huntingtin is known to associate with microtubules and synaptic vesicles at nerve terminals [65] [66] [67] , and mutant huntingtin, in a cultured PC12 cell model, impairs both the expression of the SNARE-associated protein complexin II and the release of catecholamines from dense core vesicles [68] . In light of this and the current dataset we provide here, the most probable scenario is that hyper-excitability of DA neurones enhances DA release before neurodegeneration and defects in exocytosis occur, and the latter would subsequently overcome such neuronal hyperactivity. Our data from this comparative study thus suggest that the profile of dopamine release in HD may be biphasic in nature, presymptomatic and early stages of the disease being associated with elevated levels of striatal dopamine and later stages associated with a near dearth of dopamine. Consistent with this view is the observation that YAC 128 mice exhibit a period of behavioural hyperactivity prior to the development of a motor deficit which, in turn, is followed by hypokinesis [69] , a pattern of activity that mirrors a biphasic DA profile of release.
Mechanism
The loss of SK3 channel function appears to be an early and sustained functional deficit of DA neurones in this study. It is also worth noting that we see little indication of heterogeneity between cells or between animals, suggesting that this loss of channel function is uniform and offering a potential physiological measure with which to assess the efficacy of preventative therapeutics in preclinical testing. The mechanism underlying this loss may be attributable to an interaction between the transgenic protein and the SK3 channel protein, such that these channels are rendered non-functional or are incorrectly distributed within the DA neurones. This hypothesis is clearly supported by our immunolabelling of SK3 channels as SK3 protein distribution was found to be altered in R6/1 mice. However, colocalisation between large aggregates and SK3 was not obvious, suggesting that the non-aggregated, soluble or micro-aggregated form of the transgenic protein may be the critical effector protein in the interaction. Transgenic polyglutamine proteins have been shown to exert effects upon other essential cellular components by polyglutamine-polyglutamine interactions. Several proteins containing stretches of expanded polyglutamines have been shown to be sequestered by transgenic polyglutamine-containing proteins, including TBP, CBP [70] , BRN2 [71] and NF-Y [72] . In our study, we have demonstrated, by analysing gDNA and mRNA, that the transgenic CAG repeat undergoes progressive expansion and is expressed throughout the lifetime of the R6/1-89Q line. Based upon the expansion profiles we observed, we would predict that the transgenic proteins in the individual DA neurones of the SNc carry between 89 and 143 glutamine residues. SK3 channels, encoded by the kcnn3 gene, also contain a stretch of polyglutamine residues close to the amino terminus and, therefore, constitute a potential target for sequestration by the polyglutamine-containing transgenic protein.
Our triple immunolabelling data indeed suggest that the distribution of the protein within the cell is profoundly affected and that it may be the case that the apparent increase in SK3 levels observed is due to attempts to compensate for loss of channel function. Furthermore, as CAG repeat expansion in the SNc was evident as early as at 2MO in these animals, it is easy to see how a cycle of increasing sequestration could occur during the pre-phenotypic stages of these animals' life. Thus, the R6/1-89Q mouse may provide an excellent model for further investigation of pre-manifest HD. Interestingly, polymorphisms in the CAG repeat of the kcnn3 gene have also been implicated in cognitive performance, schizophre-nia and bipolar disorder [73] [74] [75] [76] , suggesting that polyglutamine interactions are a normal aspect of SK3 channel function and/or regulation.
Based upon our observations in DA neurones, it is clear that they appear to be vulnerable to CAG repeat expansion. This vulnerability may, in itself, be a consequence, per se, of dopamine. High levels of dopamine are believed to be neurotoxic and are known to promote the formation of damaging reactive oxygen species [77] . Oxygen radicals can damage DNA, and it has been shown that repair of damaged DNA mediated by the OGG1 repair enzyme can lead to CAG repeat expansion [78] . The excitatory amino acid, glutamate, has also been shown to initiate DNA damage [79] , and this may be further aggravated by dopamine [80] . This suggests that a cycle of DNA damage, repair and expansion may occur within this cell population, with increased damage being promoted through the physiological effects of SK3 sequestration and increased levels of dopamine release in the early stages of HD. Moreover, other cells, such as medium spiny neurones, exposed to high levels of dopamine released from DA neurones may themselves be subject to DNA damage and potential CAG expansion and consequent polyglutamine-associated toxicity. Interestingly, it has been shown that an HD mouse model with raised levels of dopamine, produced by breeding with a dopamine transporter knockout mouse, developed aggregates within the striatum at an enhanced rate [32] . In the context of our experiments, an initial CAG repeat of 89Q in the mouse is sufficient to render SK3 channels dysfunctional. This observation may provide an explanation for why the drug riluzole had limited efficacy in slowing disease progression in a recent clinical trial [81] . One of the pharmacological actions of riluzole is the activation of SK3 channels [82] ; it is, therefore, possible that failure to demonstrate efficacy in the trial may be because the SK3 channels were no longer capable of being activated. In terms of the human condition, a greater understanding of the relationship between SK3 channel sequestration and the CAG repeat length of mutant huntingtin may provide critical insight into a potential tipping point in the early pathogenesis of HD.
In conclusion, the data we provide here suggest a biphasic change in dopamine bioavailability during the progression of the disease phenotype, and this reconciles a number of reports questioning the role of dopamine in HD. More importantly, our results strongly support the view that an early event in the pathogenesis of HD is a selective loss of functional SK3 channels in DA cells. These data suggest that early therapeutic interventions designed to limit the excess of dopamine, such as the dopamine-depleting agent tetrabenzine, and DNA damage in presymptomatic gene carriers may be efficacious in slowing disease progression. Furthermore, our observation in R6/1-89Q mice that changes in the evoked cell properties of mid-brain DA neurones are uniform suggests that such presymptomatic cellular phenotypes could form the basis as a means to assess the efficacy of early treatments in pre-clinical screening programmes.
